Publication | Closed Access

Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies

UrologyGenitourinary CancerMuscle-invasive Bladder CarcinomaMedicinePathologyPreliminary ActivityImmune Checkpoint InhibitorCancer TreatmentOncologyVariant Histologies